Company Overview
About Ophelia
Ophelia is a telehealth platform specializing in medication-assisted treatment (MAT) for opioid use disorder, providing access to buprenorphine (Suboxone) through online consultations and prescription management for patients across the United States. Founded in 2019 and headquartered in New York City, Ophelia addresses the severe treatment access gap in opioid addiction care — where millions of Americans with opioid use disorder cannot access MAT due to provider shortages, geographic barriers, stigma, or cost.
Business Model & Competitive Advantage
Ophelia's care model is built around online visits with licensed clinicians who can prescribe buprenorphine (following the DEA's removal of the in-person visit requirement for MAT prescriptions during COVID-19 and subsequent legislation making telemedicine prescribing permanent). Patients receive medication at their pharmacy, regular telehealth check-ins with their care team, and behavioral health support through the platform — making evidence-based addiction treatment accessible without requiring specialized in-person clinic visits.
Competitive Landscape 2025–2026
In 2025, Ophelia competes in the telehealth addiction treatment market alongside Bicycle Health, Workit Health, Eleanor Health, and traditional outpatient addiction treatment programs increasingly adding telehealth capabilities. The opioid crisis remains a devastating public health emergency — over 80,000 Americans die annually from opioid overdoses — creating immense demand for effective, accessible treatment. Ophelia's 2025 strategy focuses on expanding its state coverage (now available in 20+ states), growing insurance network partnerships to reduce out-of-pocket costs for patients, and demonstrating outcomes data showing its model's effectiveness in maintaining long-term recovery.
Open Positions
Reddit Discussions
Key Differentiators
Strong Challenger
Ophelia is an established challenger with significant market presence and competitive offerings in Healthcare.
Frequently Asked Questions
Not So Random Others
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Adni
Adni is a Singapore-headquartered AI-powered super app for healthcare workers — backed by Y Combinator with $1.38 million raised including a $1.25 million seed round in May 2022 from YC, Flare Capital
Quantinuum
Quantinuum is a Cambridge, UK and Broomfield, Colorado-based integrated quantum computing company — majority owned by Honeywell (NASDAQ: HON) with $625+ million in total funding including a $300 milli
H&M (Hennes & Mauritz)
H&M Hennes & Mauritz is a Swedish multinational fashion retailer founded in 1947, operating brands including H&M, COS, & Other Stories, ARKET, and Weekday. The company runs approximately 4,100 stores
Scaleway
Scaleway is a French cloud computing provider and subsidiary of Iliad Group, the telecommunications and technology conglomerate founded by billionaire Xavier Niel. Originally launched as Online.net in
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
Compare Ophelia with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Ophelia? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Ophelia Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Ophelia vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →